TY - JOUR
T1 - CYP2D6 mediates 4-hydroxylation of clonidine in vitro
T2 - Implication for pregnancy-induced changes in clonidine clearance
AU - Claessens, Adam J.
AU - Risler, Linda J.
AU - Eyal, Sara
AU - Shen, Danny D.
AU - Easterling, Thomas R.
AU - Hebert, Mary F.
PY - 2010/9
Y1 - 2010/9
N2 - Clonidine is a centrally acting, α-2 adrenergic agonist used for the treatment of hypertension during pregnancy. The metabolic pathways of clonidine are poorly understood, and the quantitative contribution of specific human cytochrome P450 (P450) isoforms has not been systematically assessed. In this study, 17 cDNA-expressed P450 enzymes, in addition to pooled human liver microsomes, were evaluated for clonidine 4-hydroxylation activity in vitro. Five P450 enzymes - CYP2D6, 1A2, 3A4, 1A1, and 3A5 - catalyzed measurable formation of 4-hydroxyclonidine. Selective inhibition studies in human liver microsomes confirmed that these isoforms are jointly responsible for 4-hydroxylation of clonidine in vitro, and CYP2D6 accounted for approximately two-thirds of the activity. The major role of CYP2D6 in clonidine metabolism might explain the increase in its nonrenal clearance during pregnancy.
AB - Clonidine is a centrally acting, α-2 adrenergic agonist used for the treatment of hypertension during pregnancy. The metabolic pathways of clonidine are poorly understood, and the quantitative contribution of specific human cytochrome P450 (P450) isoforms has not been systematically assessed. In this study, 17 cDNA-expressed P450 enzymes, in addition to pooled human liver microsomes, were evaluated for clonidine 4-hydroxylation activity in vitro. Five P450 enzymes - CYP2D6, 1A2, 3A4, 1A1, and 3A5 - catalyzed measurable formation of 4-hydroxyclonidine. Selective inhibition studies in human liver microsomes confirmed that these isoforms are jointly responsible for 4-hydroxylation of clonidine in vitro, and CYP2D6 accounted for approximately two-thirds of the activity. The major role of CYP2D6 in clonidine metabolism might explain the increase in its nonrenal clearance during pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=77955989948&partnerID=8YFLogxK
U2 - 10.1124/dmd.110.033878
DO - 10.1124/dmd.110.033878
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 20570945
AN - SCOPUS:77955989948
SN - 0090-9556
VL - 38
SP - 1393
EP - 1396
JO - Drug Metabolism and Disposition
JF - Drug Metabolism and Disposition
IS - 9
ER -